AIM: To determine p16 promoter hypermethylation in gastric tumoral tissue and serum samples, its impact on p16-protein expression, and correlation with clinical and histological features. METHODS: Samples were obtained from 52 histologically confirmed cases of gastric adenocarcinoma. Gastric tissue and serum of 50 age- and sex-matched individuals with normal gastroscopy and biopsy were obtained as control samples. Methylation-specific polymerase chain reaction (MSP) was used to evaluate methylation status of p16 promoter. p16-protein expression was analyzed by immunohistochemical staining on paraffin-embedded sections. RESULTS: Methylation was detected in 44.2% (23/52) of tumoral tissues. 60.9% of them were also methylated in serum, i.e., 26.9% of all patients (14/52). Methylation was not detected in tissue and sera of control samples. p16-protein expression was decreased in 61.5% of cases (32/52), and was significantly associated with promoter hypermethylation (P < 0.001). Methylation was significantly more frequent in higher pathological grades (P < 0.05). Methylation was not associated with other clinicopathological features and environmental factors including H pylori infection and smoking. CONCLUSION: p16 promoter hypermethylation is an important event in gastric carcinogenesis. It is the principle mechanism of p16 gene silencing. It is related to malignant tumor behavior. Detection of DNA methylation in serum may be a biomarker for early detection of gastric cancer.
AIM: To determine p16 promoter hypermethylation in gastric tumoral tissue and serum samples, its impact on p16-protein expression, and correlation with clinical and histological features. METHODS: Samples were obtained from 52 histologically confirmed cases of gastric adenocarcinoma. Gastric tissue and serum of 50 age- and sex-matched individuals with normal gastroscopy and biopsy were obtained as control samples. Methylation-specific polymerase chain reaction (MSP) was used to evaluate methylation status of p16 promoter. p16-protein expression was analyzed by immunohistochemical staining on paraffin-embedded sections. RESULTS: Methylation was detected in 44.2% (23/52) of tumoral tissues. 60.9% of them were also methylated in serum, i.e., 26.9% of all patients (14/52). Methylation was not detected in tissue and sera of control samples. p16-protein expression was decreased in 61.5% of cases (32/52), and was significantly associated with promoter hypermethylation (P < 0.001). Methylation was significantly more frequent in higher pathological grades (P < 0.05). Methylation was not associated with other clinicopathological features and environmental factors including H pylori infection and smoking. CONCLUSION:p16 promoter hypermethylation is an important event in gastric carcinogenesis. It is the principle mechanism of p16 gene silencing. It is related to malignant tumor behavior. Detection of DNA methylation in serum may be a biomarker for early detection of gastric cancer.
Authors: M S Wu; C T Shun; J C Sheu; H P Wang; J T Wang; W J Lee; C J Chen; T H Wang; J T Lin Journal: J Gastroenterol Hepatol Date: 1998-03 Impact factor: 4.029
Authors: Juan Carlos Roa; Leonardo Anabalón; Iván Roa; Oscar Tapia; Angélica Melo; Miguel Villaseca; Juan Carlos Araya Journal: Rev Med Chil Date: 2005-09-08 Impact factor: 0.553
Authors: Mohammad Reza Abbaszadegan; Hamid Reza Raziee; Kamran Ghafarzadegan; Mohammad Taghi Shakeri; Sima Afsharnezhad; Mohammad Reza Ghavamnasiry Journal: Int J Gastrointest Cancer Date: 2005
Authors: Alireza Sadjadi; Mehdi Nouraie; Mohammad Ali Mohagheghi; Alireza Mousavi-Jarrahi; Reza Malekezadeh; Donald Maxwell Parkin Journal: Asian Pac J Cancer Prev Date: 2005 Jul-Sep
Authors: S A Belinsky; K J Nikula; W A Palmisano; R Michels; G Saccomanno; E Gabrielson; S B Baylin; J G Herman Journal: Proc Natl Acad Sci U S A Date: 1998-09-29 Impact factor: 11.205
Authors: W K Leung; K-F To; E S H Chu; M W Y Chan; A H C Bai; E K W Ng; F K L Chan; J J Y Sung Journal: Br J Cancer Date: 2005-06-20 Impact factor: 7.640
Authors: Barbara G Schneider; M Blanca Piazuelo; Liviu A Sicinschi; Robertino Mera; Dun-Fa Peng; Juan Carlos Roa; Judith Romero-Gallo; Alberto G Delgado; Thibaut de Sablet; Luis E Bravo; Keith T Wilson; Wael El-Rifai; Richard M Peek; Pelayo Correa Journal: Epigenetics Date: 2013-08-22 Impact factor: 4.528